On the other hand, a previous study by our group [9] suggests that the evaluation of the serum levels of All-Trans Retinoic Acid -ATRA, the active form of vitamin A-should be considered as a predictive biomarker for the development of mycoses among psoriatic patients treated with IL-17 inhibitors. This evidence concerns the gene IL17A and opportunistic mycosis.